Themenkomplex I: Definitionen, Epidemiologie und natürlicher Verlauf

W. Schepp; H.-D. Allescher; T. Frieling; M. Katschinski; P. Malfertheiner; C. Pehl; U. Peitz; W. Rösch; J. Hotz †

doi:10.1055/s-2005-857871

Zeitschrift für Gastroenterologie, Table of Contents

Z Gastroenterol 2005; 43(2): 165-168
DOI: 10.1055/s-2005-857871

Leitlinie

Themenkomplex I: Definitionen, Epidemiologie und natürlicher Verlauf

W. Schepp, H.-D Allescher, T. Frieling, M. Katschinski, P. Malfertheiner, C. Pehl, U. Peitz, W. Rösch, J. Hotz †

Abstract

Full Text

References

Literatur

1 Dent J, Brun J, Frederick A. et al . An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut. 1999; 44 (Suppl 2) S1-16
2 Locke G R, Talley N J, Fett S L. et al . Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted county, Minnesota. Gastroenterology. 1997; 112 1448-1456
3 Dimenas E, Carlsson G, Glise H. et al . Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol. 1996; 31 (Suppl 221) 8-13
4 McDougall N I, Johnston B T, Kee F. et al . Natural history of reflux oesophagitis: a 10 year follow-up of its effect on patient symptomatology and quality of life. Gut. 1996; 38 481-486
5 Quigley E M. Non erosive reflux disease: part of the spectrum of gastro-oesophageal reflux disease, a component of functional dyspepsia, or both?. Eur J Gastroenterol Hepatol. 2001; 13 (Suppl 1) S13-18
6 Kulig M, Leodolter A, Vieth M. et al . Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003; 18 767-776
7 Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastrooesophageal reflux disease in an adult population. Ann Med. 1995; 27 67-70
8 Raiha I, Impivaara O, Seppala M. et al . Determinants of symptoms suggestive of gastroesophageal reflux disease in the elderly. Scand J Gastroenterol. 1993; 28 1011-1014
9 Louis E, DeLooze D, Deprez P. et al . Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources. Eur J Gastroenterol Hepatol. 2002; 14 279-284
10 Sonnenberg A, Massey B T, Jacobson S J. Hospital discharges resulting from esophagitis among Medicare beneficiaries. Dig Dis Sci. 1994; 39 183-188
11 Bardhan K D, Royston C, Nayyar A K. Reflux rising! A disease in evolution?. Gastroenterology. 2000; 118 A 478
12 El-Serag H B, Sonnenberg A. Extraesophageal complications of gastroesophageal reflux disease in US veterans. Gastroenterology. 1997; 113 755-760
13 Trudgill N J, Kapur K C, Riley S A. Familial clustering of reflux symptoms. Am J Gastroenterology. 1999; 94 1172-1178
14 Lööf L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol. 1993; 28 113-118
15 Agnew S R, Pandya S P, Reynolds R PE. et al . Predictors for frequent esophageal dilations of benign peptic strictures. Dig Dis Sci. 1996; 5 931-936
16 Jornod P, Dorta G, Pantoflickova D. et al . Peptic esophageal stricture: a vanishing complication of reflux esophagitis?. Gastroenterology. 2000; 118 A 484
17 Nayyar A K, Roysten C, Bardhan K D. Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era. Dig Liver Dis. 2003; 35 143-150
18 Kennedy T, Jones R. The prevalence of gastrooesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther. 2000; 14 1589-1594
19 Ruth M, Mansson I, Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol. 1991; 26 73-81
20 Stanghellini V. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: Results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). Scand J Gastroenterol. 1999; 231 (Suppl) 20-28
21 Kay L, Jorgensen T, Jensen K H. Epidemiology of abdominal symptoms in a random population: prevalence, incidence, and natural history. Eur J Epidemiol. 1994; 10 559-566
22 Bolin T D, Korman M G, Hansky J. et al . Heartburn: community perceptions. J Gastroenterol Hepatol. 2000; 15 35-39
23 Voutilainen M, Sipponen P, Mecklin J P. et al . Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1.128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion. 2000; 61 6-13
24 Carlsson R, Dent J, Watts R. et al . Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol. 1998; 10 119-124
25 Spechler S J. Epidemiology and natural history of gastroesophageal reflux disease. Digestion. 1992; 51 (suppl 1) 24-29
26 Triadafilopoulos G, Sharma R. Features of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol. 1997; 92 2007-2011
27 Rantanen T K, Salo J A. Gastroesophageal reflux disease as a cause of death: analysis of fatal cases under conservative treatment. Scand J Gastroenterol. 1999; 34 229-233
28 Van der Burgh A, Dees J, Hop W CJ. et al . Oesophageal cancer is an uncommon cause of death in patients with Barrett’s oesophagus. Gut. 1996; 39 5-8
29 Panos M Z, Walt R P, Stevenson C. et al . Rising death rate from non-malignant disease of the oesophagus (NMOD) in England and Wales. Gut. 1995; 36 488-491
30 Schwenkglenks M, Marbet U A, Szucs T D. Epidemiology and costs of gastroesophageal reflux disease in Swizerland: a population-based study. Soz Präventivmed. 2004; 49 51-61
31 Bloom B S, Jayadevappa R, Wahl P. et al . Time trends in cost of caring for people with gastroesophageal reflux disease. Am J Gastroenterol. 2001; 96 (suppl) S64-69
32 Wahlquist P. Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life. Am J Gastroenterol. 2001; 96 (Suppl) S57-61
33 Dean B B, Crawley J A, Schmitt C M. et al . The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther. 2003; 17 1309-1317
34 Henke C J, Levin T R, Henning J M. et al . Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol. 2000; 95 787-792
35 Glise H. Quality of life and cost of therapy in reflux disease. Scand J Gastroenterol. 1995; 30 (suppl 210) 38-42
36 Levin T R, Schmittdiel J A, Kunz K. et al . Costs of acid-related disorders to a health maintenance organization. Am J Med. 1997; 103 520-528
37 Pace F, Santalucia F, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis. Gut. 1991; 32 845-848
38 Aste H, Bonelli L, Ferraris R. et al . Gastroesophageal reflux disease. Relationship between clinical and histological features. Dig Dis Sci. 1999; 44 2412-2418
39 Kuster E, Ros E, Toledo-Pimentel V. et al . Predictive factors of the long-term outcome in gastro-oesophageal reflux disease: six-year follow-up of 107 patients. Gut. 1994; 35 8-14
40 Olloyo J B, Monnier P, Fontolliet C. et al . The natural history, prevalence and incidence of reflux esophagitis. Gullet. 1993; 3 3-10
41 Isolauri J, Luostarinen M, Isolauri E. et al . Natural course of gastroesophageal reflux disease: 17 - 22 year follow-up of 60 patients. Am J Gastroenterol. 1997; 92 37-41
42 Schindlbeck N E, Klauser A G, Berghammer G. et al . Three year follow up of patients with gastrooesophageal reflux disease. Gut. 1992; 33 1016-1019
43 Robinson N, Lanza F, Avner D. et al . Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole: a randomized, double-blind, placebo controlled trial. Ann Intern Med. 1996; 124 859-867
44 Vigneri S, Termini R, Leandro G. et al . A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med. 1995; 333 1106-1110
45 Richter J E. Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am. 2003; 32 235-261
46 Wilmer A, Tack J, Frans E. et al . Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology. 1999; 116 1293-1299
47 Miller L S, Vinayek R, Frucht H. et al . Reflux esophagitis in patients with Zollinger-Ellison syndrome. Gastroenterology. 1990; 98 341-346
48 Korsten M A, Rosman A S, Fishbein S. et al . Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med. 1991; 90 701-706
49 Shoenut J P, Wielers A, Micflikier A B. The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Aliment Pharmacol Ther. 1993; 7 509-513
50 Böhmer C JM, Klinkenberg-Knol E C, de Niezen-Boer M C. et al . Gastroesopheageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable?. Am J Gastroenterol. 2000; 95 1868-1872
51 Fujiwara Y, Nakagawa K, Kusunoki M. Gastroesophageal reflux after distal gastrectomy: possible significance of the angle of His. Am J Gastroenterol. 1998; 93 11-15
52 Rothwell J F, Lawlor P, Byrne P J. Cholecystectomy-induced gastroesophageal reflux: is it reduced by the laparoscopic approach ?. Am J Gastroenterol. 1997; 92 1351-1354
53 Cekin A H, Boyacioglu S, Gursoy M. et al . Gastroesophageal reflux disease in chronic renal failure patients with upper GI symptoms: multivariate analysis of pathogenetic factors. Am J Gastroenterol. 2002; 97 1352-1356
54 Iovino P, Ciacci C, Sabbatini F. et al . Esophageal impairment in adult celiac disease with steatorrhea. Am J Gastroenterol. 1998; 93 1243-1249
55 Lluch I, Ascaso J F, Mora F. et al . Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol. 1999; 94 919-924
56 Murray F E, Lombard M G, Ashe J. et al . Esophageal function in diabetes mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol. 1987; 82 840-843
57 Mehta A J, de Caestecker J S, Camm A J. et al . Gastro-oesophageal reflux in patients with coronary artery disease: how common is it and does it matter?. Eur J Gastroenterol Hepatol. 1996; 8 973-978
58 Avidan B, Sonnenberg A, Giblovich H. et al . Reflux symptoms are associated with psychiatric disease. Aliment Pharmacol Ther. 2001; 15 1907-1912
59 Ing A J, Ngu M C, Breslin A B. Obstructive sleep apnea and gastroesophageal reflux. Am J Med. 2000; 108 (Suppl 4a) 120S-125S
60 Rasche K, Sanner B, Schäfer T. et al . Sleep, breathing and gastroesophageal reflux. Dtsch Med Wochenschr. 1997; 122 659-663
61 Penzel T, Becker H F, Brandenburg U. et al . Arousal in patients with gastro-oesophageal reflux and sleep apnea. Eur Respir J. 1999; 14 1266-1270
62 Lagergren J, Bergstrom R, Adami H o. et al . Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000; 133 165-175
63 Achem S R, Kolts B E. Current medical therapy for esophageal motility disorders. Am J Med. 1992; 92 (suppl 5A) 98S-105S
64 Helm J F, Dodds W J, Hogan W J. et al . Acid neutralizing capacity of human saliva. Gastroenterology. 1982; 83 69-74
65 Kim S L, Hunter J G, Wo J M. et al . NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus?. J Clin Gastroenterol. 1999; 29 32-34